Amyloid-β42/40 ratio drives tau pathology in 3D human neural cell culture models of Alzheimer’s disease

Sang Su Kwak(Massachusetts General Hospital), Kevin J. Washicosky(Massachusetts General Hospital), Emma Brand(Massachusetts General Hospital), Djuna von Maydell(Massachusetts General Hospital), Jenna Aronson(Massachusetts General Hospital), Susan Kim(Massachusetts General Hospital), Diane E. Capen(Harvard University), Murat Çetinbaş(Massachusetts General Hospital), Ruslan I. Sadreyev(Massachusetts General Hospital), Shen Ning(Boston University), Enjana Bylykbashi(Massachusetts General Hospital), Weiming Xia(Boston University), Steven L. Wagner(University of California San Diego), Se Hoon Choi(Massachusetts General Hospital), Rudolph E. Tanzi(Massachusetts General Hospital), Doo Yeon Kim(Massachusetts General Hospital)
Nature Communications
March 13, 2020
Cited by 139Open Access
Full Text

Abstract

The relationship between amyloid-β (Aβ) species and tau pathology in Alzheimer's disease (AD) is not fully understood. Here, we provide direct evidence that Aβ42/40 ratio, not total Aβ level, plays a critical role in inducing neurofibrillary tangles (NTFs) in human neurons. Using 3D-differentiated clonal human neural progenitor cells (hNPCs) expressing varying levels of amyloid β precursor protein (APP) and presenilin 1 (PS1) with AD mutations, we show that pathogenic tau accumulation and aggregation are tightly correlated with Aβ42/40 ratio. Roles of Aβ42/40 ratio on tau pathology are also confirmed with APP transmembrane domain (TMD) mutant hNPCs, which display differential Aβ42/40 ratios without mutant PS1. Moreover, naïve hNPCs co-cultured with APP TMD I45F (high Aβ42/40) cells, not with I47F cells (low Aβ42/40), develop robust tau pathology in a 3D non-cell autonomous cell culture system. These results emphasize the importance of reducing the Aβ42/40 ratio in AD therapy.


Related Papers

No related papers found

Powered by citation graph analysis